Alpha-fetoprotein (AFP) Testing Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

AFP Testing Market
Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography - Forecast(2018 - 2023)
Report Code : HCR 0109
Updated Date: 10 January, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. AFP Testing – Market Overview
2. Executive Summary
3. 
AFP Testing Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. AFP Testing – Market Forces
   4.1. Drivers
      4.1.1. Increasing awareness amongst people about cancers
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. AFP Testing Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Global AFP Testing Market - By Cancer Type
   6.1. Liver Cancer
   6.2. Testes Cancer
   6.3. Ovarian Cancer
   6.4. Biliary Tract Cancer
   6.5. Stomach Cancer
   6.6. Pancreatic Cancer
   6.7. Others (Cirrhosis, and Hepatitis)
7. Global AFP Testing Market - By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. AFP Testing – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles
   9.1. Abott Laboratories
      9.1.1.  Introduction
      9.1.2. Financials
      9.1.3. Key Insights
      9.1.4. Key Strategy
      9.1.5. Product Portfolio
      9.1.6. SWOT Analysis
   9.2. Becton Dickinson 
      9.2.1. Introduction
      9.2.2. Financials
      9.2.3. Key Insights
      9.2.4. Key Strategy
      9.2.5. Product Portfolio
      9.2.6. SWOT Analysis
   9.3. Biomedical Diagnostics
      9.3.1.  Introduction
      9.3.2. Financials
      9.3.3. Key Insights
      9.3.4. Key Strategy
      9.3.5. Product Portfolio
      9.3.6. SWOT Analysis
   9.4. Bio-Rad Laboratories
      9.4.1. Introduction
      9.4.2. Financials
      9.4.3. Key Insights
      9.4.4. Key Strategy
      9.4.5. Product Portfolio
      9.4.6. SWOT Analysis
   9.5. Beckman Coulter 
      9.5.1. Introduction
      9.5.2. Financials
      9.5.3. Key Insights
      9.5.4. Key Strategy
      9.5.5. Product Portfolio
      9.5.6. SWOT Analysis
   9.6. Roche Diagnostics 
      9.6.1. Introduction
      9.6.2. Financials
      9.6.3. Key Insights
      9.6.4. Key Strategy
      9.6.5. Product Portfolio
      9.6.6. SWOT Analysis
   9.7. Kreatech Diagnostics
      9.7.1. Introduction
      9.7.2. Financials
      9.7.3. Key Insights
      9.7.4. Key Strategy
      9.7.5. Product Portfolio
      9.7.6. SWOT Analysis
   9.8. Mackay Life Sciences
      9.8.1. Introduction
      9.8.2. Financials
      9.8.3. Key Insights
      9.8.4. Key Strategy
      9.8.5. Product Portfolio
      9.8.6. SWOT Analysis
   9.9. Siemens Healthcare
      9.9.1. Introduction
      9.9.2. Financials
      9.9.3. Key Insights
      9.9.4. Key Strategy
      9.9.5. Product Portfolio
      9.9.6. SWOT Analysis
   9.10. Panacea Pharmaceuticals
      9.10.1.  Introduction
      9.10.2. Financials
      9.10.3. Key Insights
      9.10.4. Key Strategy
      9.10.5. Product Portfolio
      9.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix

   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Expert Insights
An alpha-fetoprotein (AFP) test is a blood test that measures the amount of AFP present in blood. It’s usually part of what’s called a triple screen or quad screen in the second trimester of pregnancy. The AFP protein found in humans is encoded by the AFP gene that is located on chromosome 4. The yolk sac and immature liver of an unborn baby produce AFP which then circulates through the fetal and maternal blood. Infants usually have higher levels of AFP protein which falls to normal adult level by the end of first year. AFP tests are commercially available and widely used for testing various cancer related test. AFP market is expected to increase due to increasing awareness towards cancer and globally increasing incidences of cancer and related illnesses which is also driving cancer diagnostic segment globally and is growing exponentially with huge expenditure being done on research and development activities being carried out to discover new techniques and specific antigens to further enhance the treatment mode

This report identifies the AFP Testing market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to AFP Testing market.

AFP Testing Market

Globally AFP Testing market is expected to witness growth in the upcoming future due to increasing cancer awareness and growing number of geriatric population which are more susceptible to cancer. North America represents the highest market share in the global AFP Testing market followed by Europe and Asia-Pacific with the second and third highest market share amongst all the major regions.

This market research report on global alpha-fetoprotein (AFP) Testing market is segmented based on the cancer type, as follows: Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer and Others (Cirrhosis, and Hepatitis)

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for alpha-fetoprotein in each of the region.

This report identifies all the major companies operating in the AFP Testing market. Some of the major companies’ profiles in detail are as follows:
  • Abott Laboratories
  • Becton Dickinson 
  • Biomedical Diagnostics
  • Bio-Rad Laboratories
  • Beckman Coulter 
  • Roche Diagnostics 
List of Tables

Table1 Alpha-fetoprotein (AFP) Testing Market Overview 2017-2023
Table2 Alpha-fetoprotein (AFP) Testing Market Leader Analysis 2017-2018 (US$)
Table3 Alpha-fetoprotein (AFP) Testing MarketProduct Analysis 2017-2018 (US$)
Table4 Alpha-fetoprotein (AFP) Testing MarketEnd User Analysis 2017-2018 (US$)
Table5 Alpha-fetoprotein (AFP) Testing MarketPatent Analysis 2013-2018* (US$)
Table6 Alpha-fetoprotein (AFP) Testing MarketFinancial Analysis 2017-2018 (US$)
Table7 Alpha-fetoprotein (AFP) Testing Market Driver Analysis 2017-2018 (US$)
Table8 Alpha-fetoprotein (AFP) Testing MarketChallenges Analysis 2017-2018 (US$)
Table9 Alpha-fetoprotein (AFP) Testing MarketConstraint Analysis 2017-2018 (US$)
Table10 Alpha-fetoprotein (AFP) Testing Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table11 Alpha-fetoprotein (AFP) Testing Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table12 Alpha-fetoprotein (AFP) Testing Market Threat of Substitutes Analysis 2017-2018 (US$)
Table13 Alpha-fetoprotein (AFP) Testing Market Threat of New Entrants Analysis 2017-2018 (US$)
Table14 Alpha-fetoprotein (AFP) Testing Market Degree of Competition Analysis 2017-2018 (US$)
Table15 Alpha-fetoprotein (AFP) Testing MarketValue Chain Analysis 2017-2018 (US$)
Table16 Alpha-fetoprotein (AFP) Testing MarketPricing Analysis 2018-2023 (US$)
Table17 Alpha-fetoprotein (AFP) Testing MarketOpportunities Analysis 2018-2023 (US$)
Table18 Alpha-fetoprotein (AFP) Testing MarketProduct Life Cycle Analysis 2018-2023 (US$)
Table19 Alpha-fetoprotein (AFP) Testing MarketSupplier Analysis 2017-2018 (US$)
Table20 Alpha-fetoprotein (AFP) Testing MarketDistributor Analysis 2017-2018 (US$)
Table21 Alpha-fetoprotein (AFP) Testing Market Trend Analysis 2017-2018 (US$)
Table22 Alpha-fetoprotein (AFP) Testing Market Size 2017 (US$)
Table23 Alpha-fetoprotein (AFP) Testing Market Forecast Analysis 2018-2023 (US$)
Table24 Alpha-fetoprotein (AFP) Testing Market Sales Forecast Analysis 2018-2023 (Units)
Table25 Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2018-2023 ($)
Table26 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Liver Cancer, 2018-2023 ($)
Table27 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Testes Cancer, 2018-2023 ($)
Table28 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Ovarian Cancer, 2018-2023 ($)
Table29 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Biliary Tract Cancer, 2018-2023 ($)
Table30 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Stomach Cancer, 2018-2023 ($)
Table31 North America Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2018-2023 ($)
Table32 South america Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2018-2023 ($)
Table33 Europe Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2018-2023 ($)
Table34 APAC Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2018-2023 ($)
Table35 Middle East & Africa Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2018-2023 ($)
Table36 Russia Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2018-2023 ($)
Table37 Israel Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2018-2023 ($)
Table38 Top Companies 2017 (US$)Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,,
Table39 Product Launch 2017-2018Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,,
Table40 Mergers & Acquistions 2017-2018Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,,


List of Figures

Figure 1 Overview of Alpha-fetoprotein (AFP) Testing Market 2017-2023
Figure 2 Market Share Analysis for Alpha-fetoprotein (AFP) Testing Market 2017 (US$)
Figure 3 Product Comparison in Alpha-fetoprotein (AFP) Testing Market 2017-2018 (US$)
Figure 4 End User Profile for Alpha-fetoprotein (AFP) Testing Market 2017-2018 (US$)
Figure 5 Patent Application and Grant in Alpha-fetoprotein (AFP) Testing Market 2013-2018* (US$)
Figure 6 Top 5 Companies Financial Analysis in Alpha-fetoprotein (AFP) Testing Market 2017-2018 (US$)
Figure 7 Market Entry Strategy in Alpha-fetoprotein (AFP) Testing Market 2017-2018
Figure 8 Ecosystem Analysis in Alpha-fetoprotein (AFP) Testing Market2017
Figure 9 Average Selling Price in Alpha-fetoprotein (AFP) Testing Market 2017-2023
Figure 10 Top Opportunites in Alpha-fetoprotein (AFP) Testing Market 2017-2018
Figure 11 Market Life Cycle Analysis in Alpha-fetoprotein (AFP) Testing MarketMarket Life Cycle Analysis in 3D Printing
Figure 12 GlobalBy Cancer TypeAlpha-fetoprotein (AFP) Testing Market Revenue, 2018-2023 ($)
Figure 13 Global Alpha-fetoprotein (AFP) Testing Market - By Geography
Figure 14 Global Alpha-fetoprotein (AFP) Testing Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 15 Global Alpha-fetoprotein (AFP) Testing Market CAGR, By Geography, 2018-2023 (%)
Figure 16 North America Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 17 US Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 18 US GDP and Population, 2017-2018 ($)
Figure 19 US GDP – Composition of 2017, By Sector of Origin
Figure 20 US Export and Import Value & Volume, 2017-2018 ($)
Figure 21 Canada Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 22 Canada GDP and Population, 2017-2018 ($)
Figure 23 Canada GDP – Composition of 2017, By Sector of Origin
Figure 24 Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 25 Mexico Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 26 Mexico GDP and Population, 2017-2018 ($)
Figure 27 Mexico GDP – Composition of 2017, By Sector of Origin
Figure 28 Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 29 South America Alpha-fetoprotein (AFP) Testing MarketSouth America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 30 Brazil Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 31 Brazil GDP and Population, 2017-2018 ($)
Figure 32 Brazil GDP – Composition of 2017, By Sector of Origin
Figure 33 Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 34 Venezuela Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 35 Venezuela GDP and Population, 2017-2018 ($)
Figure 36 Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 37 Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 38 Argentina Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 39 Argentina GDP and Population, 2017-2018 ($)
Figure 40 Argentina GDP – Composition of 2017, By Sector of Origin
Figure 41 Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 42 Ecuador Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 43 Ecuador GDP and Population, 2017-2018 ($)
Figure 44 Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 45 Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 46 Peru Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 47 Peru GDP and Population, 2017-2018 ($)
Figure 48 Peru GDP – Composition of 2017, By Sector of Origin
Figure 49 Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 50 Colombia Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 51 Colombia GDP and Population, 2017-2018 ($)
Figure 52 Colombia GDP – Composition of 2017, By Sector of Origin
Figure 53 Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 54 Costa Rica Alpha-fetoprotein (AFP) Testing MarketCosta Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 55 Costa Rica GDP and Population, 2017-2018 ($)
Figure 56 Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 57 Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 58 Europe Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 59 U.K Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 60 U.K GDP and Population, 2017-2018 ($)
Figure 61 U.K GDP – Composition of 2017, By Sector of Origin
Figure 62 U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 63 Germany Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 64 Germany GDP and Population, 2017-2018 ($)
Figure 65 Germany GDP – Composition of 2017, By Sector of Origin
Figure 66 Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 67 Italy Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 68 Italy GDP and Population, 2017-2018 ($)
Figure 69 Italy GDP – Composition of 2017, By Sector of Origin
Figure 70 Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 71 France Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 72 France GDP and Population, 2017-2018 ($)
Figure 73 France GDP – Composition of 2017, By Sector of Origin
Figure 74 France Export and Import Value & Volume, 2017-2018 ($)
Figure 75 Netherlands Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 76 Netherlands GDP and Population, 2017-2018 ($)
Figure 77 Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 78 Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 79 Belgium Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 80 Belgium GDP and Population, 2017-2018 ($)
Figure 81 Belgium GDP – Composition of 2017, By Sector of Origin
Figure 82 Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 83 Spain Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 84 Spain GDP and Population, 2017-2018 ($)
Figure 85 Spain GDP – Composition of 2017, By Sector of Origin
Figure 86 Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 87 Denmark Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 88 Denmark GDP and Population, 2017-2018 ($)
Figure 89 Denmark GDP – Composition of 2017, By Sector of Origin
Figure 90 Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 91 APAC Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 92 China Alpha-fetoprotein (AFP) Testing MarketValue & Volume, 2018-2023
Figure 93 China GDP and Population, 2017-2018 ($)
Figure 94 China GDP – Composition of 2017, By Sector of Origin
Figure 95 China Export and Import Value & Volume, 2017-2018 ($)Alpha-fetoprotein (AFP) Testing MarketChina Export and Import Value & Volume, 2017-2018 ($)
Figure 96 Australia Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 97 Australia GDP and Population, 2017-2018 ($)
Figure 98 Australia GDP – Composition of 2017, By Sector of Origin
Figure 99 Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 100 South Korea Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 101 South Korea GDP and Population, 2017-2018 ($)
Figure 102 South Korea GDP – Composition of 2017, By Sector of Origin
Figure 103 South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 104 India Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 105 India GDP and Population, 2017-2018 ($)
Figure 106 India GDP – Composition of 2017, By Sector of Origin
Figure 107 India Export and Import Value & Volume, 2017-2018 ($)
Figure 108 Taiwan Alpha-fetoprotein (AFP) Testing MarketTaiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 109 Taiwan GDP and Population, 2017-2018 ($)
Figure 110 Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 111 Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 112 Malaysia Alpha-fetoprotein (AFP) Testing MarketMalaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 113 Malaysia GDP and Population, 2017-2018 ($)
Figure 114 Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 115 Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 116 Hong Kong Alpha-fetoprotein (AFP) Testing MarketHong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 117 Hong Kong GDP and Population, 2017-2018 ($)
Figure 118 Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 119 Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 120 Middle East & Africa Alpha-fetoprotein (AFP) Testing MarketMiddle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 121 Russia Alpha-fetoprotein (AFP) Testing MarketRussia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122 Russia GDP and Population, 2017-2018 ($)
Figure 123 Russia GDP – Composition of 2017, By Sector of Origin
Figure 124 Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 125 Israel Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2018-2023 ($)
Figure 126 Israel GDP and Population, 2017-2018 ($)
Figure 127 Israel GDP – Composition of 2017, By Sector of Origin
Figure 128 Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 129 Entropy Share, By Strategies, 2017-2018* (%)Alpha-fetoprotein (AFP) Testing Market
Figure 130 Developments, 2017-2018*Alpha-fetoprotein (AFP) Testing Market
Figure 131 Company 1 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 132 Company 1 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 133 Company 1 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 134 Company 2 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 135 Company 2 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 136 Company 2 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 137 Company 3Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 138 Company 3Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 139 Company 3Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 140 Company 4 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 141 Company 4 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 142 Company 4 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 143 Company 5 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 144 Company 5 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 145 Company 5 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 146 Company 6 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 147 Company 6 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 148 Company 6 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 149 Company 7 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 150 Company 7 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 151 Company 7 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 152 Company 8 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 153 Company 8 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 154 Company 8 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 155 Company 9 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 156 Company 9 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 157 Company 9 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 158 Company 10 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 159 Company 10 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 160 Company 10 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 161 Company 11 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 162 Company 11 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 163 Company 11 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 164 Company 12 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 165 Company 12 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 166 Company 12 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 167 Company 13Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 168 Company 13Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 169 Company 13Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 170 Company 14 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 171 Company 14 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 172 Company 14 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Figure 173 Company 15 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2017-2018* ($)
Figure 174 Company 15 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2017 (%)
Figure 175 Company 15 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll